These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2975225)

  • 1. Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands.
    Mansbach RS; Geyer MA
    Eur J Pharmacol; 1988 Nov; 156(3):375-83. PubMed ID: 2975225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.
    Davis M; Cassella JV; Kehne JH
    Psychopharmacology (Berl); 1988; 94(1):14-20. PubMed ID: 2894698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.
    Gilbert F; Dourish CT
    Psychopharmacology (Berl); 1987; 93(3):349-52. PubMed ID: 2893412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acoustic startle, conditioned startle potentiation and the effects of 8-OH-DPAT and buspirone in rats selectively bred for differences in 8-OH-DPAT-induced hypothermia.
    McQueen DA; Overstreet DH; Ardayfio PA; Commissaris RL
    Behav Pharmacol; 2001 Nov; 12(6-7):509-16. PubMed ID: 11742145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by 8-hydroxy-2-(di-n-propylamino) tetralin and SM-3997, a novel anxiolytic drug, of the hippocampal rhythmical slow activity mediated by 5-hydroxytryptamine1A receptors.
    Hirose A; Tsuji R; Shimizu H; Tatsuno T; Tanaka H; Kumasaka Y; Nakamura M
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):8-13. PubMed ID: 1969119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1987 Jun; 138(1):29-36. PubMed ID: 2887435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid discrimination of the stimulus properties of 5-hydroxytryptamine agonists using conditioned taste aversion.
    Lucki I
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1120-7. PubMed ID: 2974486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of helpless behavior in rats by putative 5-HT1A agonists.
    Giral P; Martin P; Soubrié P; Simon P
    Biol Psychiatry; 1988 Feb; 23(3):237-42. PubMed ID: 2892540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex.
    Rigdon GC; Weatherspoon JK
    J Pharmacol Exp Ther; 1992 Nov; 263(2):486-93. PubMed ID: 1432685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of the serotonergic compound eltoprazine.
    Ybema CE; Slangen JL; Olivier B; Mos J
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1045-51. PubMed ID: 1532031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
    Gilbert F; Dourish CT; Brazell C; McClue S; Stahl SM
    Psychoneuroendocrinology; 1988; 13(6):471-8. PubMed ID: 2907164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.
    Gilbert F; Brazell C; Tricklebank MD; Stahl SM
    Eur J Pharmacol; 1988 Mar; 147(3):431-9. PubMed ID: 2897920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of 5HT1A receptors induces lower lip retraction in the rat.
    Berendsen HH; Jenck F; Broekkamp CL
    Pharmacol Biochem Behav; 1989 Aug; 33(4):821-7. PubMed ID: 2533357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
    Söderpalm B; Hjorth S; Engel JA
    Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement by the putative 5-HT receptor agonist 8-OH-2-(di-n-propylamino)tetralin of the acoustic startle response in the rat.
    Svensson L; Ahlenius S
    Psychopharmacology (Berl); 1983; 79(2-3):104-7. PubMed ID: 6221350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.